APA (7th ed.) Citation

King, L. A., Veth, M., Roos, M., Scheffer, G. L., Popovic, M. A., de Gruijl, T. D., & van der Vliet, H. J. (2025). PD-L1 directed bispecific Vδ2-T cell engager combines lysis of PD-L1 expressing tumor cells with PD-1 immune checkpoint inhibition and modulation of the tumor immune microenvironment. Journal for immunotherapy of cancer, 13(10), e012255. https://doi.org/10.1136/jitc-2025-012255

Chicago Style (17th ed.) Citation

King, Lisa A., Myrthe Veth, Marieke Roos, George L. Scheffer, Marko A. Popovic, Tanja D. de Gruijl, and Hans J. van der Vliet. "PD-L1 Directed Bispecific Vδ2-T Cell Engager Combines Lysis of PD-L1 Expressing Tumor Cells with PD-1 Immune Checkpoint Inhibition and Modulation of the Tumor Immune Microenvironment." Journal for Immunotherapy of Cancer 13, no. 10 (2025): e012255. https://doi.org/10.1136/jitc-2025-012255.

MLA (9th ed.) Citation

King, Lisa A., et al. "PD-L1 Directed Bispecific Vδ2-T Cell Engager Combines Lysis of PD-L1 Expressing Tumor Cells with PD-1 Immune Checkpoint Inhibition and Modulation of the Tumor Immune Microenvironment." Journal for Immunotherapy of Cancer, vol. 13, no. 10, 2025, p. e012255, https://doi.org/10.1136/jitc-2025-012255.